| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Original Studies |
Department of Pediatrics, University of Brussels (C.H., J.P.C.), Brussels; the Department of Pediatrics, University of Ghent (M.C.), Ghent; the Department of Pediatrics, University of Louvain (P.M.), Brussels; and the Department of Pediatrics, University of Liege (J.P.B.), Liege; and the Belgian Study Group for Pediatric Endocrinology (K.L., D.X.H.), Belgium
Address all correspondence and requests for reprints to: Prof. J. P. Bourguignon, Division of Pediatric and Adolescent Medicine, University of Liege, Centre Hospitalier Universitaire Sart Tilman, B-4000 Liege, Belgium.
This study evaluated the perception of stature, acceptance of therapy, and psychosocial functioning in relation to age at onset and time on treatment during 2 yr of GH therapy in 31 girls with Turners syndrome grouped by age (group A: 3.75.8 yr, n = 9; group B: 7.211.8 yr, n = 13; group C: 12.516.4 yr, n = 9). The growth response after 2 yr was significant in the 3 groups when calculated in terms of growth norms for untreated Turner girls (mean increase in height SD score: +1.2, +1.5, and +1.1, respectively). The effect was less marked in terms of growth norms for normal girls, particularly in group B (+0.5 SD score). Height was perceived as a problem by most patients, except in the youngest girls at the start of treatment (group A) and in the majority of the adolescents after 2 yr of GH therapy (group C), without evidence of relation to growth response during therapy. The GH injections were fairly well accepted by all patients, except those younger than 6 yr. In all patients, expected adult height was unrealistic and became more realistic with age, whereas no consistent changes were observed in relation to growth response to GH therapy. The Child Behavior Checklist revealed elevated mean scores at the behavioral subscales of attention problems (group A and B), social problems, withdrawal, and anxiety-depression (most obviously in group B). No significant changes were seen during GH therapy. In group C, an elevated mean social problem score at the Youth Self Report and a low mean social self-esteem score at the Self-Esteem Inventory were observed before therapy and showed a significant improvement during 2 yr of GH treatment. These results, however, might be biased due to an increase in social desirability during therapy. We conclude that the perception of height, acceptance of GH therapy, and psychosocial functioning in girls with Turners syndrome show important differences between age groups, with only slight changes observed during GH therapy.
This article has been cited by other articles:
![]() |
L. D Voss Is short stature a problem? The psychological view Eur. J. Endocrinol., November 1, 2006; 155(suppl_1): S39 - S45. [Abstract] [Full Text] [PDF] |
||||
![]() |
J.-C. Carel, C. Elie, E. Ecosse, M. Tauber, J. Leger, S. Cabrol, M. Nicolino, R. Brauner, J.-L. Chaussain, and J. Coste Self-Esteem and Social Adjustment in Young Women with Turner Syndrome--Influence of Pubertal Management and Sexuality: Population-Based Cohort Study J. Clin. Endocrinol. Metab., August 1, 2006; 91(8): 2972 - 2979. [Abstract] [Full Text] [PDF] |
||||
![]() |
The Canadian Growth Hormone Advisory Committee Impact of Growth Hormone Supplementation on Adult Height in Turner Syndrome: Results of the Canadian Randomized Controlled Trial J. Clin. Endocrinol. Metab., June 1, 2005; 90(6): 3360 - 3366. [Abstract] [Full Text] [PDF] |
||||
![]() |
J.-C. Carel, E. Ecosse, I. Bastie-Sigeac, S. Cabrol, M. Tauber, J. Leger, M. Nicolino, R. Brauner, J.-L. Chaussain, and J. Coste Quality of Life Determinants in Young Women with Turner's Syndrome after Growth Hormone Treatment: Results of the StaTur Population-Based Cohort Study J. Clin. Endocrinol. Metab., April 1, 2005; 90(4): 1992 - 1997. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. K. van Pareren, H. J. Duivenvoorden, F. S. M. Slijper, H. M. Koot, and A. C. S. Hokken-Koelega Intelligence and Psychosocial Functioning during Long-Term Growth Hormone Therapy in Children Born Small for Gestational Age J. Clin. Endocrinol. Metab., November 1, 2004; 89(11): 5295 - 5302. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Massa, C. Heinrichs, S. Verlinde, M. Thomas, J. P. Bourguignon, M. Craen, I. Francois, M. Du Caju, M. Maes, and J. De Schepper Late or Delayed Induced or Spontaneous Puberty in Girls with Turner Syndrome Treated with Growth Hormone Does Not Affect Final Height J. Clin. Endocrinol. Metab., September 1, 2003; 88(9): 4168 - 4174. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. A. Lee, J. W. Kendig, and J. R. Kerrigan Persistent Short Stature, Other Potential Outcomes, and the Effect of Growth Hormone Treatment in Children Who Are Born Small for Gestational Age Pediatrics, July 1, 2003; 112(1): 150 - 162. [Full Text] [PDF] |
||||
![]() |
H. Guyda Four Decades of Growth Hormone Therapy for Short Children: What Have We Achieved? J. Clin. Endocrinol. Metab., December 1, 1999; 84(12): 4307 - 4316. [Full Text] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |